Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The affinity purification company will set up shop at the former Merck & Co./GlycoFi facility in the Dartmouth Regional Technology Center in New Hampshire.

Avitide Plants Flag at Former Merck Location

The project involves installation of a small-scale pressured agitated nutsche filter dryer in glass, integrated in a high-containment isolator to achieve an occupational exposure limit of less than 1 microgram per meter cube, 8-hour time weighted average.

Powder Systems Limited Installs High-Containment Filter Dryer in Australian API Manufacturing Plant

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.

Merck Receives Breakthrough Therapy Designation for Ebola Vaccine

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Gamma-stable fluoropolymers are an alternative material for single-use bags and assemblies in biopharmaceutical manufacturing.

Considering Single-Use Materials

The collaboration will focus on the investigational candidate JTX-2011 and up to four other early-stage programs in immune-oncology.

Celgene Partners with Jounce Therapeutics for Immunotherapy Development

The antisense drug will be the first in the companies’ joint development deal for medications to treat autoimmune disorders of the gastrointestinal tract.

Ionis Pharmaceuticals Licenses Oral RNA-based Therapeutic to Janssen

FDA issued a warning letter to the Worthing, UK facility for cross contamination and microbial contamination cGMP violations.

SmithKline Beecham Gets Warned for Contamination

The agency says the increasing requests for orphan drug designation has resulted in a change in FDA’s review goals.

FDA Adjusts Review Timeline to Keep Up with Orphan Drug Demand

FDA reviewers have found that Sandoz's GP2015, a biosimilar version of Amgen's Enbrel, is highly similar to the original product in terms of purity, safety, and potency.

Sandoz's Biosimilar to Enbrel Gets FDA Support Ahead of Panel

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

A Federal Circuit court ruled biosimilar makers must wait 180 days after receiving FDA approval before bringing drugs to market.